Clinical Trial Update: Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study [NA]

View source ↗

Summary

An exploratory cross-sectional study completed at Yonsei University evaluated contrast-enhanced ultrasound using Sonazoid to screen for hepatocellular carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Sonazoid (perflubutane)

Snippet

Sponsor: Yonsei University | Conditions: Hepatocellular Carcinoma (HCC) | NA | Status: COMPLETED